Expertise in
11
conditions

Dr. Randolph B. Deger

Obstetrics and Gynecology
Virtua Gynecologic Oncology Specialists
200 Bowman Dr Ste E315, 
Voorhees, NJ 
Accepting New Patients
Expertise in
11
conditions
Virtua Gynecologic Oncology Specialists
200 Bowman Dr Ste E315, 
Voorhees, NJ 

Overview

Randolph Deger is an Obstetrics and Gynecologist practicing medicine in Voorhees, New Jersey.

Dr. Deger is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Ureteral Reconstruction, and Hysterectomy.

He is actively involved in clinical research, participating in 6 clinical trials. Dr. Deger is currently accepting new patients.

Specialties

Obstetrics and Gynecology

Licenses

Obstetrics & Gynecology in NJ

Hospital Affiliations

Virtua Mount Holly Hospital
West Jersey Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

Virtua Gynecologic Oncology Specialists
200 Bowman Dr Ste E315, Voorhees, NJ 08043

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer
A Phase III Randomized Trial of Radiation +/- Pembrolizumab (MK-3475) for Newly Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (dMMR) Endometrioid Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Other, Procedure, Radiation, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
Enrollment Status: Active_not_recruiting
Publish Date: March 24, 2026
Intervention Type: Drug, Procedure
Study Drugs: Carboplatin, Letrozole, Paclitaxel
Study Phase: Phase 3
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
Enrollment Status: Active_not_recruiting
Publish Date: December 30, 2025
Intervention Type: Other, Drug, Biological
Study Drugs: Bevacizumab, Carboplatin, Docetaxel, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 3
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Enrollment Status: Completed
Publish Date: May 23, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Cisplatin
Study Phase: Phase 3
A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
A Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin in Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
Enrollment Status: Unknown
Publish Date: March 29, 2023
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
Enrollment Status: Unknown
Publish Date: September 30, 2021
Intervention Type: Other, Drug
Study Drugs: Carboplatin, Metformin hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
View 5 Less Clinical Trials
Similar Doctors
Expertise in
10
conditions
Dr. Paul Nyirjesy
Obstetrics and Gynecology
Expertise in
10
conditions
Dr. Paul Nyirjesy
Obstetrics and Gynecology
Referral may be required

Jefferson OB/GYN – Center City

833 Chestnut Street (Entrance Near 8th Street), 
Philadelphia, PA 
 (13.0 miles away)
215-955-5000
Languages Spoken:
English
See accepted insurances

Paul Nyirjesy is an Obstetrics and Gynecologist practicing medicine in Philadelphia, Pennsylvania. Dr. Nyirjesy is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Vaginal Yeast Infection, Vulvovaginitis, Thrush, and Vulvodynia. Dr. Nyirjesy is board certified in Obstetrics & Gynecology.

Expertise in
11
conditions
Dr. Lily A. Arya
Obstetrics and Gynecology
Expertise in
11
conditions
Dr. Lily A. Arya
Obstetrics and Gynecology
Referral may be required

Penn Health For Women University City

3737 Market Street, 12th Floor, 
Philadelphia, PA 
 (14.9 miles away)
Languages Spoken:
English
See accepted insurances

Lily Arya is an Obstetrics and Gynecologist practicing medicine in Philadelphia, Pennsylvania. Dr. Arya is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Urinary Incontinence, Stress Urinary Incontinence, Frequent or Urgent Urination, Sacral Nerve Stimulation, and Vaginectomy. Dr. Arya is board certified in Ob/Gyn - Female Pelvic Medicine And Reconstructive Surgery, 2013 and Obstetrics And Gynecology, 2002.

Expertise in
10
conditions
Dr. Heidi S. Harvie
Obstetrics and Gynecology
Expertise in
10
conditions
Dr. Heidi S. Harvie
Obstetrics and Gynecology
Referral may be required

Penn Urogynecology Washington Square

800 Walnut Street, 10th Floor, 
Philadelphia, PA 
 (12.7 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances

Heidi Harvie is an Obstetrics and Gynecologist practicing medicine in Philadelphia, Pennsylvania. Dr. Harvie is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Uterine Prolapse, Urinary Incontinence, Stress Urinary Incontinence, Hysterectomy, and Sacral Nerve Stimulation. Dr. Harvie is board certified in Ob/Gyn - Female Pelvic Medicine And Reconstructive Surgery, 2014 and Obstetrics And Gynecology, 2008.

Frequently Asked Questions about Dr. Randolph B. Deger

How do I make an appointment with Dr. Randolph B. Deger?

You can book an appointment with Dr. Randolph B. Deger by calling their office at 856-288-1735. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Randolph B. Deger a top-rated expert for Endometrial Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Randolph B. Deger is classified as an Distinguished expert for Endometrial Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Randolph B. Deger specialize in?

While Dr. Randolph B. Deger is a Obstetrics and Gynecology, they have specific expertise in Endometrial Cancer, Ovarian Carcinosarcoma, and Sertoli-Leydig Cell Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Obstetrics and Gynecology.

Does Dr. Randolph B. Deger accept my insurance?

Dr. Randolph B. Deger accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 856-288-1735 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Deger's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile